Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
News Alert: FDA highlights safety issue with leadless pacemakers
Thursday, November 18, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra

All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra

Share on Twitter Share on Facebook Share on Linkedin
All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Major recalls hit cardiology | AI approvals continue | Robotic mitral repair | Rising interest in LBBAP
Key details about the Evoque TTVR device | Rising interest in LBBAP | AI detects 'fingerprints' in the eye that predict strokes
More surgical devices recalled over ongoing safety concerns | Worrisome disparities in care for PAD patients
Momentum continues for renal denervation | The 'new era' of HFpEF treatment | A world record for heart transplants
Heart monitor software recalled over failure to send alerts | Why EP needs a champion | Medtronic expands carotid portfolio
Cardiology still a leader in AI approvals | Robotic mitral repair vs. conventional surgery | J&J gains key approval
Week in Review: J&J puts research on hold | The best diets for heart health | Boston Scientific enters IVL arms race

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …97
    • Page 98
    • Page 99
    • Page 100
    • Current page 101
    • Page 102
    • Page 103
    • Page 104
    • Page 105 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme